BioCryst Pharmaceuticals | Stock



Stock Veränderung Datum
Alnylam Pharmaceuticals USD 65.58M 12.93M 2025-03
Chugai Pharma JPY 240.07B 33.13B 2024-12
Daiichi Sankyo JPY 475.36B 22.27B 2024-12
Gilead Sciences USD 3.59B 154M 2024-12
GlaxoSmithKline GBP 6B 331M 2025-03
Glaxosmithkline 5.67B 249M 2024-12
Incyte USD 63.97M 5.1M 2025-03
Ionis Pharmaceuticals USD 11.5M 1.01M 2025-03
Neurocrine Biosciences USD 57.4M 11.6M 2024-12
PTC Therapeutics USD 35.67M 3.84M 2024-09
Regeneron Pharmaceuticals USD 3.97B 879M 2025-03
Roche Holding CHF 7.61B 339M 2024-12
Sarepta Therapeutics USD 749.96M 184.04M 2024-12
Ultragenyx Pharmaceutical USD 45.01M 1.67M 2024-12
Vertex Pharmaceuticals USD 1.21B 125.6M 2024-12



BioCryst Pharmaceuticals Stock - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.